Before the identification of IL-17, an upregulation of the IL-12/IFN-γ signaling pathway was considered as the major driving disease mechanism in psoriasis since elevated IFN-γ levels were correlated with disease severity and were observed in serum and skin samples (both lesional and non-lesional) (32). The gene discussed is IL17A; the disease is psoriasis.